Title: MMWR Vol. 59 / No. RR-6
| If you have trouble reading this e-mail, please click here.
|
|
|
Recommendations and Reports
Volume 59, No. RR-6
July 23, 2010
|
|
|
|
|
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
|
|
|
|
|
| These recommendations from the Advisory Committee on Immunization Practices (ACIP) update the previous recommendations for anthrax vaccine adsorbed (AVA) and reflect the status of anthrax vaccine supplies in the United States. Substantial changes to these recommendations include the following: 1) reducing the number of doses required to complete the pre-event and preexposure primary
series from 6 doses to 5 doses, 2) recommending intramuscular rather than subcutaneous AVA administration for preexposure use, 3) recommending AVA as a component of postexposure prophylaxis in pregnant women exposed to aerosolized Bacillus anthracis spores, 4) providing guidance regarding preexposure vaccination of emergency and other responder organizations under the direction of an occupational health program, and 5) recommending 60 days of antimicrobial prophylaxis in conjunction with
3 doses of AVA for optimal protection of previously unvaccinated persons after exposure to aero¬solized B. anthracis spores.
|
|
 full text
|
|
|
|
Department of Health and Human Services
Centers for Disease Control and Prevention
|
|
|
Modify/Update Subscriber Preferences | Unsubscribe | Send Feedback | Learn more about CDC Email Updates
To receive the latest news for your region, please update your profile with your country, state and zip code.
Questions or problems? Please contact support@xxxxxxxxxxxxxxx.
Centers for Disease Control and Prevention (CDC) · 1600 Clifton Rd · Atlanta GA 30333 · 800-CDC-INFO (800-232-4636)
